{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:13:29Z","timestamp":1792271609929,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20385"],"award-info":[{"award-number":["U22A20385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The heart, an organ with a continuously high demand for energy, inherently lacks substantial reserves. The precise mechanisms that prioritize energy allocation to cardiac mitochondria, ensuring steady-state ATP production amidst high-energy organs, remain poorly understood. Our study sheds light on this process by identifying a two-strata flux system driven by the starvation hormone FGF21. We demonstrate that systemic disruptions in interorgan metabolite mobilization and transcardiac flux, arising from either adipose lipolysis or hepatic ketogenesis due to FGF21 deficiency, directly impair cardiac energetic performance. Locally, this impairment is linked to compromised intracardiac utilization of various metabolites via ketolysis and oxidation pathways, along with hindered mitochondrial biogenesis, TCA cycle, ETC flow, and OXPHOS. Consequently, the heart shifts to a hypometabolic, glycolytic, and hypoenergy state, with a reduced capacity to cope with physiological stressors such as fasting, starvation, strenuous exercise, endurance training, and cold exposure, leading to a diminished heart rate, contractility, and hemodynamic stability. Pharmacological or genetic restoration of FGF21 ameliorates these defects, reenergizing stress-exhausted hearts. This hierarchical energy-prioritizing mechanism is orchestrated by the LKB1-AMPK-mTOR energy stress response pathways. Disrupting cardiac LKB1 or mTOR pathways, akin to stalling mitochondrial energy conduits, obstructs the FGF21-governed cardiac energetic potential. Our findings reveal an essential two-strata energy flux system critical for cardiac energetic efficiency regulated by FGF21, which spatiotemporally optimizes interorgan and transcardiac metabolite flux and intracardiac mitochondrial energy sufficiency. This discovery informs the design of strategies for treating cardiac diseases linked to mitochondrial or energy deficiencies.<\/jats:p>","DOI":"10.1038\/s41392-025-02402-9","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T23:03:37Z","timestamp":1758841417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A two-strata energy flux system driven by a stress hormone prioritizes cardiac energetics"],"prefix":"10.1038","volume":"10","author":[{"given":"Zhiheng","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhui","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Vengai","family":"Mukondiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wumengwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8269-6731","authenticated-orcid":false,"given":"Zhifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-6262","authenticated-orcid":false,"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongde","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"2402_CR1","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R. & Abel, E. D. Cardiac energy metabolism in heart failure. Circ. Res. 128, 1487\u20131513 (2021).","journal-title":"Circ. Res."},{"key":"2402_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvx017","volume":"113","author":"J Ritterhoff","year":"2017","unstructured":"Ritterhoff, J. & Tian, R. Metabolism in cardiomyopathy: every substrate matters. Cardiovasc. Res. 113, 411\u2013421 (2017).","journal-title":"Cardiovasc. Res."},{"key":"2402_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","volume":"133","author":"G Aubert","year":"2016","unstructured":"Aubert, G. et al. The failing heart relies on ketone bodies as a fuel. Circulation 133, 698\u2013705 (2016).","journal-title":"Circulation"},{"key":"2402_CR4","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.120.052671","volume":"143","author":"AN Carley","year":"2021","unstructured":"Carley, A. N. et al. Short-chain fatty acids outpace ketone oxidation in the failing heart. Circulation 143, 1797\u20131808 (2021).","journal-title":"Circulation"},{"key":"2402_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","volume":"5","author":"MK Badman","year":"2007","unstructured":"Badman, M. K. et al. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426\u2013437 (2007).","journal-title":"Cell Metab."},{"key":"2402_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki, T. et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415\u2013425 (2007).","journal-title":"Cell Metab."},{"key":"2402_CR7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.cmet.2019.08.019","volume":"30","author":"S Forsstrom","year":"2019","unstructured":"Forsstrom, S. et al. Fibroblast growth factor 21 drives dynamics of local and systemic stress responses in mitochondrial myopathy with mtDNA deletions. Cell Metab. 30, 1040\u20131054 e1047 (2019).","journal-title":"Cell Metab."},{"key":"2402_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.celrep.2018.07.023","volume":"24","author":"LM Restelli","year":"2018","unstructured":"Restelli, L. M. et al. Neuronal mitochondrial dysfunction activates the integrated stress response to induce fibroblast growth factor 21. Cell Rep. 24, 1407\u20131414 (2018).","journal-title":"Cell Rep."},{"key":"2402_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cmet.2016.01.006","volume":"23","author":"C Schlein","year":"2016","unstructured":"Schlein, C. et al. FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues. Cell Metab. 23, 441\u2013453 (2016).","journal-title":"Cell Metab."},{"key":"2402_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cmet.2017.07.007","volume":"26","author":"NA Khan","year":"2017","unstructured":"Khan, N. A. et al. mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression. Cell Metab. 26, 419\u2013428 e415 (2017).","journal-title":"Cell Metab."},{"key":"2402_CR11","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1212\/WNL.0000000000003374","volume":"87","author":"JM Lehtonen","year":"2016","unstructured":"Lehtonen, J. M. et al. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders. Neurology 87, 2290\u20132299 (2016).","journal-title":"Neurology"},{"key":"2402_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","volume":"10","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen, A. et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10, 806\u2013818 (2011).","journal-title":"Lancet Neurol."},{"key":"2402_CR13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627\u20131635 (2005).","journal-title":"J. Clin. Invest."},{"key":"2402_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep33953","volume":"6","author":"RH Chou","year":"2016","unstructured":"Chou, R. H. et al. Circulating fibroblast growth factor 21 is associated with diastolic dysfunction in heart failure patients with preserved ejection fraction. Sci. Rep. 6, 33953 (2016).","journal-title":"Sci. Rep."},{"key":"2402_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12933-017-0588-5","volume":"16","author":"Y Shen","year":"2017","unstructured":"Shen, Y. et al. Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death. Cardiovasc. Diabetol. 16, 106 (2017).","journal-title":"Cardiovasc. Diabetol."},{"key":"2402_CR16","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1210\/jc.2016-2308","volume":"101","author":"Q Li","year":"2016","unstructured":"Li, Q. et al. Association between serum fibroblast growth factor 21 and mortality among patients with coronary artery disease. J. Clin. Endocrinol. Metab. 101, 4886\u20134894 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2402_CR17","doi-asserted-by":"publisher","first-page":"7138776","DOI":"10.1155\/2022\/7138776","volume":"2022","author":"L Fan","year":"2022","unstructured":"Fan, L., Gu, L., Yao, Y. & Ma, G. Elevated serum fibroblast growth factor 21 is relevant to heart failure patients with reduced ejection fraction. Comput. Math. Methods Med. 2022, 7138776 (2022).","journal-title":"Comput. Math. Methods Med."},{"key":"2402_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.celrep.2018.03.070","volume":"23","author":"TM Frayling","year":"2018","unstructured":"Frayling, T. M. et al. A common allele in FGF21 associated with sugar intake is associated with body shape, lower total body-fat percentage, and higher blood pressure. Cell Rep. 23, 327\u2013336 (2018).","journal-title":"Cell Rep."},{"key":"2402_CR19","doi-asserted-by":"publisher","first-page":"155616","DOI":"10.1016\/j.metabol.2023.155616","volume":"145","author":"A Giontella","year":"2023","unstructured":"Giontella, A. et al. Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study. Metabolism 145, 155616 (2023).","journal-title":"Metabolism"},{"key":"2402_CR20","doi-asserted-by":"crossref","unstructured":"Larsson, S. C. & Gill, D. Genetic evidence supporting fibroblast growth factor 21 signalling as a pharmacological target for cardiometabolic outcomes and Alzheimer\u2019s disease. Nutrients 13, 1504 (2021).","DOI":"10.3390\/nu13051504"},{"key":"2402_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","volume":"18","author":"G Gaich","year":"2013","unstructured":"Gaich, G. et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 18, 333\u2013340 (2013).","journal-title":"Cell Metab."},{"key":"2402_CR22","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41591-021-01425-3","volume":"27","author":"SA Harrison","year":"2021","unstructured":"Harrison, S. A. et al. Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. Nat. Med. 27, 1262\u20131271 (2021).","journal-title":"Nat. Med."},{"key":"2402_CR23","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","volume":"392","author":"A Sanyal","year":"2019","unstructured":"Sanyal, A. et al. Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial. Lancet 392, 2705\u20132717 (2019).","journal-title":"Lancet"},{"key":"2402_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3019","volume":"4","author":"A Planavila","year":"2013","unstructured":"Planavila, A. et al. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. Nat. Commun. 4, 2019 (2013).","journal-title":"Nat. Commun."},{"key":"2402_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cvr\/cvu263","volume":"106","author":"A Planavila","year":"2015","unstructured":"Planavila, A. et al. Fibroblast growth factor 21 protects the heart from oxidative stress. Cardiovasc. Res. 106, 19\u201331 (2015).","journal-title":"Cardiovasc. Res."},{"key":"2402_CR26","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1194\/jlr.M044784","volume":"55","author":"MK Brahma","year":"2014","unstructured":"Brahma, M. K. et al. Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis. J. Lipid Res. 55, 2229\u20132241 (2014).","journal-title":"J. Lipid Res."},{"key":"2402_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/path.5226","volume":"248","author":"G Ferrer-Curriu","year":"2019","unstructured":"Ferrer-Curriu, G. et al. Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease. J. Pathol. 248, 30\u201340 (2019).","journal-title":"J. Pathol."},{"key":"2402_CR28","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1210\/en.2009-0532","volume":"150","author":"MK Badman","year":"2009","unstructured":"Badman, M. K., Koester, A., Flier, J. S., Kharitonenkov, A. & Maratos-Flier, E. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 150, 4931\u20134940 (2009).","journal-title":"Endocrinology"},{"key":"2402_CR29","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1210\/en.2009-0119","volume":"150","author":"Y Hotta","year":"2009","unstructured":"Hotta, Y. et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150, 4625\u20134633 (2009).","journal-title":"Endocrinology"},{"key":"2402_CR30","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1073\/pnas.0904187106","volume":"106","author":"MJ Potthoff","year":"2009","unstructured":"Potthoff, M. J. et al. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. USA106, 10853\u201310858 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2402_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ymgme.2020.09.001","volume":"131","author":"G Elizondo","year":"2020","unstructured":"Elizondo, G., Matern, D., Vockley, J., Harding, C. O. & Gillingham, M. B. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD\/TFPD. Mol. Genet. Metab. 131, 90\u201397 (2020).","journal-title":"Mol. Genet. Metab."},{"key":"2402_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.mam.2004.06.007","volume":"25","author":"ME Rubio-Gozalbo","year":"2004","unstructured":"Rubio-Gozalbo, M. E., Bakker, J. A., Waterham, H. R. & Wanders, R. J. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol. Asp. Med. 25, 521\u2013532 (2004).","journal-title":"Mol. Asp. Med."},{"key":"2402_CR33","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1073\/pnas.92.23.10496","volume":"92","author":"AW Strauss","year":"1995","unstructured":"Strauss, A. W. et al. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. Proc. Natl Acad. Sci. USA92, 10496\u201310500 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2402_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41556-023-01297-4","volume":"26","author":"RG Lee","year":"2024","unstructured":"Lee, R. G. et al. Quantitative subcellular reconstruction reveals a lipid mediated inter-organelle biogenesis network. Nat. Cell Biol. 26, 57\u201371 (2024).","journal-title":"Nat. Cell Biol."},{"key":"2402_CR35","doi-asserted-by":"publisher","first-page":"112846","DOI":"10.1016\/j.celrep.2023.112846","volume":"42","author":"A Murari","year":"2023","unstructured":"Murari, A. et al. Phospholipids can regulate complex I assembly independent of their role in maintaining mitochondrial membrane integrity. Cell Rep. 42, 112846 (2023).","journal-title":"Cell Rep."},{"key":"2402_CR36","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.cmet.2019.03.011","volume":"29","author":"E Sanchez-Lopez","year":"2019","unstructured":"Sanchez-Lopez, E. et al. Choline uptake and metabolism modulate macrophage IL-1beta and IL-18 production. Cell Metab. 29, 1350\u20131362 e1357 (2019).","journal-title":"Cell Metab."},{"key":"2402_CR37","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1172\/JCI117894","volume":"95","author":"JC Brackett","year":"1995","unstructured":"Brackett, J. C. et al. Two alpha subunit donor splice site mutations cause human trifunctional protein deficiency. J. Clin. Invest. 95, 2076\u20132082 (1995).","journal-title":"J. Clin. Invest."},{"key":"2402_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj3510","volume":"378","author":"M Al-Habsi","year":"2022","unstructured":"Al-Habsi, M. et al. Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice. Science 378, eabj3510 (2022).","journal-title":"Science"},{"key":"2402_CR39","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1038\/nm.4222","volume":"22","author":"T Eisenberg","year":"2016","unstructured":"Eisenberg, T. et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat. Med. 22, 1428\u20131438 (2016).","journal-title":"Nat. Med."},{"key":"2402_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016055","volume":"9","author":"A Nayak","year":"2020","unstructured":"Nayak, A. et al. N8-acetylspermidine: a polyamine biomarker in ischemic cardiomyopathy with reduced ejection fraction. J. Am. Heart Assoc. 9, e016055 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"2402_CR41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cmet.2019.05.003","volume":"30","author":"DJ Puleston","year":"2019","unstructured":"Puleston, D. J. et al. Polyamines and eIF5A hypusination modulate mitochondrial respiration and macrophage activation. Cell Metab. 30, 352\u2013363 e358 (2019).","journal-title":"Cell Metab."},{"key":"2402_CR42","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cmet.2019.07.001","volume":"30","author":"LO Leiria","year":"2019","unstructured":"Leiria, L. O. et al. 12-lipoxygenase regulates cold adaptation and glucose metabolism by producing the omega-3 Lipid 12-HEPE from brown fat. Cell Metab. 30, 768\u2013783 e767 (2019).","journal-title":"Cell Metab."},{"key":"2402_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S2213-8587(20)30148-0","volume":"8","author":"MB Schulze","year":"2020","unstructured":"Schulze, M. B., Minihane, A. M., Saleh, R. N. M. & Riserus, U. Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases. Lancet Diabetes Endocrinol. 8, 915\u2013930 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2402_CR44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm1231","volume":"11","author":"K Takayama","year":"2005","unstructured":"Takayama, K. et al. Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat. Med. 11, 562\u2013566 (2005).","journal-title":"Nat. Med."},{"key":"2402_CR45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/cvr\/27.3.396","volume":"27","author":"M Karmazyn","year":"1993","unstructured":"Karmazyn, M., Tani, M. & Neely, J. R. Effect of prostaglandins I2 (prostacyclin) and F2 alpha on function, energy metabolism, and calcium uptake in ischaemic\/reperfused hearts. Cardiovasc. Res. 27, 396\u2013402 (1993).","journal-title":"Cardiovasc. Res."},{"key":"2402_CR46","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1016\/j.febslet.2012.08.020","volume":"586","author":"M Davids","year":"2012","unstructured":"Davids, M., Ndika, J. D., Salomons, G. S., Blom, H. J. & Teerlink, T. Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett. 586, 3653\u20133657 (2012).","journal-title":"FEBS Lett."},{"key":"2402_CR47","doi-asserted-by":"publisher","first-page":"e2348333","DOI":"10.1001\/jamanetworkopen.2023.48333","volume":"6","author":"N Mahemuti","year":"2023","unstructured":"Mahemuti, N. et al. Urinary albumin-to-creatinine ratio in normal range, cardiovascular health, and all-cause mortality. JAMA Netw. Open 6, e2348333 (2023).","journal-title":"JAMA Netw. Open"},{"key":"2402_CR48","doi-asserted-by":"crossref","unstructured":"Deng, Y. et al. An adipo-biliary-uridine axis that regulates energy homeostasis. Science 355, 1173\u20131182 (2017).","DOI":"10.1126\/science.aaf5375"},{"key":"2402_CR49","doi-asserted-by":"publisher","first-page":"15070","DOI":"10.1073\/pnas.0405173101","volume":"101","author":"Y Kirino","year":"2004","unstructured":"Kirino, Y. et al. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc. Natl. Acad. Sci. USA101, 15070\u201315075 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2402_CR50","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1073\/pnas.79.10.3300","volume":"79","author":"DT Chuang","year":"1982","unstructured":"Chuang, D. T., Ku, L. S. & Cox, R. P. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate. Proc. Natl. Acad. Sci. USA79, 3300\u20133304 (1982).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2402_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00726-021-03110-8","volume":"54","author":"S Komine","year":"2022","unstructured":"Komine, S. et al. Taurine supplementation enhances endurance capacity by delaying blood glucose decline during prolonged exercise in rats. Amino Acids 54, 251\u2013260 (2022).","journal-title":"Amino Acids"},{"key":"2402_CR52","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-024-07801-6","volume":"633","author":"W Wei","year":"2024","unstructured":"Wei, W. et al. PTER is a N-acetyltaurine hydrolase that regulates feeding and obesity. Nature 633, 182\u2013188 (2024).","journal-title":"Nature"},{"key":"2402_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pcad.2018.01.009","volume":"61","author":"JJ DiNicolantonio","year":"2018","unstructured":"DiNicolantonio, J. J., Liu, J. & O\u2019Keefe, J. H. Thiamine and Cardiovascular Disease: A Literature Review. Prog. Cardiovasc. Dis. 61, 27\u201332 (2018).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"2402_CR54","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.yjmcc.2008.03.001","volume":"44","author":"T Ito","year":"2008","unstructured":"Ito, T. et al. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J. Mol. Cell. Cardiol. 44, 927\u2013937 (2008).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2402_CR55","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1126\/science.3616607","volume":"237","author":"PD Pion","year":"1987","unstructured":"Pion, P. D., Kittleson, M. D., Rogers, Q. R. & Morris, J. G. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237, 764\u2013768 (1987).","journal-title":"Science"},{"key":"2402_CR56","doi-asserted-by":"publisher","first-page":"33ra37","DOI":"10.1126\/scitranslmed.3001006","volume":"2","author":"GD Lewis","year":"2010","unstructured":"Lewis, G. D. et al. Metabolic signatures of exercise in human plasma. Sci. Transl. Med. 2, 33ra37 (2010).","journal-title":"Sci. Transl. Med."},{"key":"2402_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41586-022-05041-0","volume":"609","author":"B Niemann","year":"2022","unstructured":"Niemann, B. et al. Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine. Nature 609, 361\u2013368 (2022).","journal-title":"Nature"},{"key":"2402_CR58","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cmet.2023.06.015","volume":"35","author":"JH Sohn","year":"2023","unstructured":"Sohn, J. H. et al. Liver mitochondrial cristae organizing protein MIC19 promotes energy expenditure and pedestrian locomotion by altering nucleotide metabolism. Cell Metab. 35, 1356\u20131372 e1355 (2023).","journal-title":"Cell Metab."},{"key":"2402_CR59","doi-asserted-by":"crossref","unstructured":"Tong, L. et al. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity. Cell Metab. 36, 1013\u20131029 (2024).","DOI":"10.1016\/j.cmet.2024.03.003"},{"key":"2402_CR60","doi-asserted-by":"publisher","first-page":"35839","DOI":"10.1074\/jbc.M109.057273","volume":"284","author":"Y Ikeda","year":"2009","unstructured":"Ikeda, Y. et al. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction. J. Biol. Chem. 284, 35839\u201335849 (2009).","journal-title":"J. Biol. Chem."},{"key":"2402_CR61","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/cvr\/28.7.1003","volume":"28","author":"JG Kingma Jr","year":"1994","unstructured":"Kingma, J. G. Jr, Simard, D. & Rouleau, J. R. Timely administration of AICA riboside reduces reperfusion injury in rabbits. Cardiovasc. Res. 28, 1003\u20131007 (1994).","journal-title":"Cardiovasc. Res."},{"key":"2402_CR62","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1126\/science.adh2771","volume":"383","author":"U Sahu","year":"2024","unstructured":"Sahu, U. et al. Pyrimidines maintain mitochondrial pyruvate oxidation to support de novo lipogenesis. Science 383, 1484\u20131492 (2024).","journal-title":"Science"},{"key":"2402_CR63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cmet.2010.02.001","volume":"11","author":"E Hondares","year":"2010","unstructured":"Hondares, E. et al. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metab. 11, 206\u2013212 (2010).","journal-title":"Cell Metab."},{"key":"2402_CR64","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.tem.2021.04.013","volume":"32","author":"P Icard","year":"2021","unstructured":"Icard, P., Alifano, M., Donnadieu, E. & Simula, L. Fructose-1,6-bisphosphate promotes PI3K and glycolysis in T cells?. Trends Endocrinol. Metab. 32, 540\u2013543 (2021).","journal-title":"Trends Endocrinol. Metab."},{"key":"2402_CR65","doi-asserted-by":"crossref","unstructured":"Sullivan, A. I. et al. Characterization of FGF21 Sites of Production and Signaling in Mice. Endocrinology 165, bqae120 (2024).","DOI":"10.1210\/endocr\/bqae120"},{"key":"2402_CR66","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1445-5994.1980.tb04250.x","volume":"10","author":"FL Mastaglia","year":"1980","unstructured":"Mastaglia, F. L., Thompson, P. L. & Papadimitriou, J. M. Mitochondrial myopathy with cardiomyopathy, lactic acidosis and response to prednisone and thiamine. Aust. N. Z. J. Med. 10, 660\u2013664 (1980).","journal-title":"Aust. N. Z. J. Med."},{"key":"2402_CR67","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nm.2439","volume":"17","author":"G Haemmerle","year":"2011","unstructured":"Haemmerle, G. et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat. Med. 17, 1076\u20131085 (2011).","journal-title":"Nat. Med."},{"key":"2402_CR68","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/bj1480403","volume":"148","author":"LH Opie","year":"1975","unstructured":"Opie, L. H. & Owen, P. Effects of increased mechanical work by isolated perfused rat heart during production or uptake of ketone bodies. Assessment of mitochondrial oxidized to reduced free nicotinamide-adenine dinucleotide ratios and oxaloacetate concentrations. Biochem. J. 148, 403\u2013415 (1975).","journal-title":"Biochem. J."},{"key":"2402_CR69","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1210\/en.2016-1710","volume":"157","author":"M Ye","year":"2016","unstructured":"Ye, M. et al. FGF21-FGFR1 coordinates phospholipid homeostasis, lipid droplet function, and ER stress in obesity. Endocrinology 157, 4754\u20134769 (2016).","journal-title":"Endocrinology"},{"key":"2402_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molmet.2012.08.007","volume":"2","author":"AC Adams","year":"2012","unstructured":"Adams, A. C. et al. The breadth of FGF21 metabolic actions are governed by FGFR1 in adipose tissue. Mol. Metab. 2, 31\u201337 (2012).","journal-title":"Mol. Metab."},{"key":"2402_CR71","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00065","volume":"1","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife 1, e00065 (2012).","journal-title":"Elife"},{"key":"2402_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-025-02710-y","volume":"24","author":"CMA Cefalo","year":"2025","unstructured":"Cefalo, C. M. A. et al. Relationship between hemoglobin glycation index and myocardial mechano-energetic efficiency in non-diabetic individual. Cardiovasc. Diabetol. 24, 148 (2025).","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02402-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02402-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02402-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T23:03:39Z","timestamp":1758841419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02402-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2402"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02402-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}